Correlation Between Queste Communications and Nova Eye

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Queste Communications and Nova Eye at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Queste Communications and Nova Eye into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Queste Communications and Nova Eye Medical, you can compare the effects of market volatilities on Queste Communications and Nova Eye and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Queste Communications with a short position of Nova Eye. Check out your portfolio center. Please also check ongoing floating volatility patterns of Queste Communications and Nova Eye.

Diversification Opportunities for Queste Communications and Nova Eye

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Queste and Nova is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Queste Communications and Nova Eye Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nova Eye Medical and Queste Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Queste Communications are associated (or correlated) with Nova Eye. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nova Eye Medical has no effect on the direction of Queste Communications i.e., Queste Communications and Nova Eye go up and down completely randomly.

Pair Corralation between Queste Communications and Nova Eye

Assuming the 90 days trading horizon Queste Communications is expected to generate 0.51 times more return on investment than Nova Eye. However, Queste Communications is 1.96 times less risky than Nova Eye. It trades about 0.07 of its potential returns per unit of risk. Nova Eye Medical is currently generating about 0.01 per unit of risk. If you would invest  2.40  in Queste Communications on August 29, 2024 and sell it today you would earn a total of  2.50  from holding Queste Communications or generate 104.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Queste Communications  vs.  Nova Eye Medical

 Performance 
       Timeline  
Queste Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Queste Communications has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Queste Communications is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Nova Eye Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nova Eye Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Queste Communications and Nova Eye Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Queste Communications and Nova Eye

The main advantage of trading using opposite Queste Communications and Nova Eye positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Queste Communications position performs unexpectedly, Nova Eye can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nova Eye will offset losses from the drop in Nova Eye's long position.
The idea behind Queste Communications and Nova Eye Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device